Status:
UNKNOWN
Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)
Lead Sponsor:
Sheba Medical Center
Conditions:
Bone Density
Eligibility:
All Genders
1-7 years
Brief Summary
SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not...
Eligibility Criteria
Inclusion
- Term newborn infants to mothers treated with SSRI and healthy controls
Exclusion
- Preterms, major congenital malformations.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00818727
Start Date
February 1 2009
Last Update
January 8 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.